Literature DB >> 24633490

Effects of interleukin-11 on the expression of human bone sialoprotein gene.

Hiroyoshi Matsumura1, Yohei Nakayama, Hideki Takai, Yorimasa Ogata.   

Abstract

Interleukin-11 (IL-11) is a bone marrow stromal fibroblast-derived cytokine with a wide spectrum of activities in different biological systems. IL-11 and IL-6 are two cytokines known to rely on osteoblast-osteoclast communication for their effects on osteoclast differentiation. Bone sialoprotein (BSP) is a mineralized connective tissue-specific protein expressed in differentiated osteoblasts, odontoblasts, and cementoblasts. To determine the molecular basis of the transcriptional regulation of the human BSP gene by IL-11, we conducted real-time polymerase chain reactions (PCR), transient transfection analyses with chimeric constructs of the human BSP gene promoter linked to a luciferase reporter gene, gel mobility shift assays, and a chromatin immunoprecipitation assay using human osteoblast-like Saos2 cells. IL-11 (20 ng/ml) increased BSP, Runx2, and Osterix mRNA levels at 6 h and the alkaline phosphatase (ALP) mRNA level at 12 h in osteoblast-like Saos2 cells. In a transient transfection assay, IL-11 (20 ng/ml, 12 h) increased luciferase activities of constructs between -60LUC and -868LUC including the human BSP gene promoter. Transcriptional stimulations by IL-11 were partially inhibited in the constructs that included 2-bp mutations in the cAMP response element 1 (CRE1, -72 to -79) and CRE2 (-667 to -674). When mutations were made in pairs of CRE1 and CRE2 in -868LUC, the effect of IL-11 on luciferase activity was almost totally abrogated. Transcriptional activities induced by IL-11 were inhibited by protein kinase A, tyrosine kinase, ERK1/2, and PI3-kinase inhibitors. Gel mobility shift analyses showed that IL-11 increased nuclear proteins binding to CRE1 and CRE2. CREB1, phospho-CREB1, c-Fos, and c-Jun antibodies disrupted the formation of CRE1 and CRE2 protein complexes. These data demonstrate that IL-11 stimulates BSP gene transcription via CRE1 and CRE2 elements in the human BSP gene promoter.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633490     DOI: 10.1007/s00774-014-0576-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  57 in total

1.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

2.  Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene.

Authors:  Youhei Nakayama; Yu Nakajima; Naoko Kato; Hideki Takai; Dong-Soon Kim; Masato Arai; Masaru Mezawa; Shouta Araki; Jaro Sodek; Yorimasa Ogata
Journal:  J Cell Physiol       Date:  2006-08       Impact factor: 6.384

3.  Transforming growth factor-beta 1 regulation of bone sialoprotein gene transcription: identification of a TGF-beta activation element in the rat BSP gene promoter.

Authors:  Y Ogata; N Niisato; S Furuyama; S Cheifetz; R H Kim; H Sugiya; J Sodek
Journal:  J Cell Biochem       Date:  1997-06-15       Impact factor: 4.429

4.  Human bone sialoprotein. Deduced protein sequence and chromosomal localization.

Authors:  L W Fisher; O W McBride; J D Termine; M F Young
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

5.  The human bone sialoprotein gene (IBSP): genomic localization and characterization.

Authors:  J M Kerr; L W Fisher; J D Termine; M G Wang; O W McBride; M F Young
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

6.  Differentiation-specific increase of cAMP-dependent protein kinase in the 3T3-L1 cells.

Authors:  A Y Liu
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

7.  An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements.

Authors:  Tamotsu Kiyoshima; Masato Yamauchi; Cherrie Wong; Andrew Jheon; Bernhard Ganss; Jaro Sodek
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

8.  Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP.

Authors:  E Shimizu-Sasaki; M Yamazaki; S Furuyama; H Sugiya; J Sodek; Y Ogata
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

9.  Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor.

Authors:  Chunxi Ge; Guozhi Xiao; Di Jiang; Qian Yang; Nan E Hatch; Hernan Roca; Renny T Franceschi
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

10.  Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence.

Authors:  R H Kim; H S Shapiro; J J Li; J L Wrana; J Sodek
Journal:  Matrix Biol       Date:  1994-01       Impact factor: 11.583

View more
  3 in total

1.  Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.

Authors:  Xuhui Zhang; Hai Wu; Jason R Dobson; Gillian Browne; Deli Hong; Jacqueline Akech; Lucia R Languino; Gary S Stein; Jane B Lian
Journal:  J Cell Biochem       Date:  2015-09       Impact factor: 4.429

Review 2.  Mechanobiology of Periodontal Ligament Stem Cells in Orthodontic Tooth Movement.

Authors:  Huaming Huang; Ruili Yang; Yan-Heng Zhou
Journal:  Stem Cells Int       Date:  2018-09-17       Impact factor: 5.443

Review 3.  Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis.

Authors:  Marie-Therese Haider; Nicole Ridlmaier; Daniel J Smit; Hanna Taipaleenmäki
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.